UBS ASSET MANAGEMENT AMERICAS LLC - PROMETHEUS BIOSCIENCES INC ownership

PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 103 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of PROMETHEUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2023$1,979,8380.0%18,4480.0%0.00%0.0%
Q1 2023$1,979,838
-2.8%
18,448
-0.4%
0.00%0.0%
Q4 2022$2,037,640
-99.4%
18,524
+198.8%
0.00%
Q3 2022$365,862,000
+56.3%
6,2000.0%0.00%
Q1 2022$234,112,0006,2000.00%
Other shareholders
PROMETHEUS BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 1,848,024$73,071,00064.85%
CHI Advisors LLC 1,752,243$69,283,00023.00%
Cormorant Asset Management, LP 1,848,024$73,071,0004.35%
Waypoint Capital Advisors, LLC 152,665$6,036,0004.14%
Perceptive Advisors 6,345,570$250,904,0001.94%
RTW INVESTMENTS, LP 3,264,031$129,060,0001.88%
Eventide Asset Management 3,742,507$145,120,0001.85%
Octagon Capital Advisors LP 200,000$7,908,0001.54%
PLATINUM INVESTMENT MANAGEMENT LTD 521,529$20,621,0000.57%
Rock Springs Capital Management LP 618,407$24,452,0000.56%
View complete list of PROMETHEUS BIOSCIENCES INC shareholders